Johnson & Johnson (NYSE: JNJ) announced today that the U.S. Food and Drug Administration (FDA) approved RYBREVANT FASPRO™ (amivantamab and hyaluronidase-lpuj), the first and only subcutaneously (SC) ...
Behind closed doors in Washington, top advisers made a series of decisions that had devastating repercussions for the poorest ...
For Deadline's Backstory video series, the creative team behind HBO's 'Task' discussed the making of a key scene in Episode 3 ...
The feature, available via a new Disco app, taps Gemini 3 to suggest and build apps based on what you're doing online. Is it ...